Overview
International law firm McDermott Will & Schulte represented Ren Life Sciences on its investment in AMW GmbH, a company specialising in the development and commercialisation of long acting formulations of sterile injectable drugs. Growth in the number of complex large molecule medicines which require parenteral administration is driving demand for technology which can extend the therapeutic window. In turn, this improves patient access, comfort and adherence. Ren Life Sciences and Juno Capital Partners invested alongside existing shareholders SHS Capital and AMW Evolution.
McDermott’s cross-border team was led by partner Fatema Orjela and included counsel Zoe Woodhouse, associate Raees Khan and trainee solicitor Sofia Vargas Velasco (all private equity). The team was supported in London by partners Alex Jupp (tax) and Raminta Dereskeviciute (regulatory) and in Germany by partners Johannes Eckhardt, Carsten Böhm, Sebastian Bonk, Philipp Grenzebach, counsel Manuel Weiß, with associates Carlota Huth and Julia Külzer (all private equity), partners Dustin Schwerdtfeger (corporate finance), Florian Schiefer (tax), Laura Stammwitz (foreign investment), Jana Grieb (healthcare), Boris Uphoff and Steffen Woitz (IP litigation), Maximilian Clostermeyer (real estate), Christian Driessen-Rolf (employment), counsel Claus Färber (intellectual property), and associates Matthias Bosbach (corporate finance), Carolin Schumacher (antitrust), Carina Schützeberg (healthcare), Paulina Simons (intellectual property), Athanasia Eleftheriadou (employment), Thomas Hintzen (public law).
Ren Life Sciences is a specialist investment firm focused on backing Europe’s fastest-growing Life Science businesses. Ren supports companies with sustainable technological or scientific differentiation in their journey to accelerate the delivery of innovative therapies to patients, and the creation of highly-paid scientific jobs in Europe.
About Us
Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.